A synthetic peptide for use as a blocking control in assays to test for specificity of SBDS antibody, Alternative Names: SBDS control peptide, SBDS antibody Blocking Peptide, Anti-SBDS Blocking Peptide, Shwachman-Bodian-Diamond Syndrome Blocking Peptide, CGI-97 Blocking Peptide, FLJ10917 Blocking Peptide, SDS Blocking Peptide, SWDS Blocking Peptide
SBDS
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
SBDS
(Shwachman-Bodian-Diamond Syndrome (SBDS))
Hintergrund
SBDS is a member of a highly conserved protein family that exists from archaea to vertebrates and plants. The protein may function in RNA metabolism. Mutations within its gene are associated with Shwachman-Bodian-Diamond syndrome.